Product Images Lacosamide Oral Solution

This is a description of Lacosamide Oral Solution, USP with a concentration of 100 mg per 10 mL, packaged by Kesin Pharma Corporation in Oldsmar, FL. It is intended for institutional use only and comes in 10 x 10 mL unit dose cups with an expiration date of "00-AUG-0000" and a LOT number of "KO0O00000". It should be stored at 68°F to 77°F (20°C to 25°C). Further information can be found in the insert for internal use only.*

This is a description of an oral solution medication with the NDC code 81033-427-17 containing lacosamide at a concentration of 150 mg per 15 mL. It is intended for institutional use with packaging consisting of 10 x 15 mL unit dose cups. The product is manufactured and distributed by Kesin Pharma Corporation based in Oldsmar, FL. The expiration date is mentioned as 00-AUG-0000, the lot number is KO0O00000, and storage instructions recommend keeping it at 68°F to 77°F (20°C to 25°C). Additional information may be available in the insert provided with the product.*

This text provides information about Lacosamide Oral Solution in 200 mg per 20 mL dosage, packaged and distributed by Kesin Pharma Corporation. It is for institutional use only and comes in 10 x 20 mL unit dose cups. The product should be stored at 68°F to 77°F (20°C to 25°C). The expiration date and LOT number are also mentioned. Additional instructions to see the insert and indication for internal use are highlighted.*

This text contains information about Lacosamide Oral Solution, USP with a concentration of 50 mg per 5 mL. It is a prescription medication packaged and distributed by Kesin Pharma Corporation in Oldsmar, FL. The product is intended for institutional use only and is available in 10 x 5 mL unit dose cups. The expiration date and lot number are provided, along with storage instructions. Please see the insert for further details.*

The text provides information about responder rates, improvement, and worsening in relation to the use of Lacosamide Oral Solution and Placebo. Figure 2 illustrates the proportion of patients based on responder rates for Lacosamide in different dosages compared to the placebo groups in Studies 2, 3, and 4. The text also shows the number of patients in each treatment group for different dosages of Lacosamide.*